Evaluation of Soft Tissue Mass on Right Hepatic Flexure of Colon
For a soft tissue mass at the right hepatic flexure of the colon, obtain contrast-enhanced CT of the abdomen and pelvis as the initial imaging study, followed by percutaneous core needle biopsy under image guidance to establish histopathological diagnosis before any definitive treatment. 1
Initial Imaging Approach
The right hepatic flexure represents an intra-abdominal/retroperitoneal location where CT is the preferred diagnostic modality rather than MRI or ultrasound 2. This differs from extremity soft tissue masses where the evaluation pathway starts differently.
Why CT First for This Location:
- CT provides complete staging information on the same scan for intra-abdominal and retroperitoneal masses 1
- CT is superior for evaluating visceral and retroperitoneal sarcomas where it serves dual purposes: diagnosis AND staging 2
- The multiplanar capability allows assessment of the mass's relationship to adjacent bowel, vasculature, and other abdominal structures 2
- CT can identify calcification patterns and characterize mineralization that may be diagnostic 2
CT Protocol Specifics:
Obtain CT with IV contrast (or CT without and with IV contrast if subtle calcification needs characterization) 2. The contrast phases help distinguish the mass from surrounding tissues and assess vascularity.
Critical Next Step: Referral Before Biopsy
Any retroperitoneal or intra-abdominal mass with imaging appearances suggestive of soft tissue sarcoma should be referred to a specialist sarcoma MDT BEFORE surgical treatment 1. This is a fundamental tenet—if your institution cannot perform definitive imaging or treatment, refer before biopsy 2.
Biopsy Approach
Once imaging is complete and specialist referral made:
Standard Biopsy Technique:
- Percutaneous core needle biopsy under image guidance is the standard approach 1
- Take multiple cores to maximize diagnostic yield 1
- Plan the biopsy tract so it can be safely removed at definitive surgery 1
- Fine needle aspiration is NOT recommended as primary diagnostic modality 1
Important Caveat:
The risk of tract seeding is very small, but biopsy planning remains important surgical practice 1. However, never let biopsy tract concerns prevent obtaining a pre-treatment histological diagnosis 1.
Staging Workup
Once sarcoma is confirmed histologically, complete staging includes:
- CT chest to exclude pulmonary metastases (the predominant metastatic pattern) 1
- The abdominal/pelvic CT already obtained serves as visceral staging 1
- For specific histologies (myxoid liposarcoma, leiomyosarcoma), abdominal and pelvic imaging is particularly important as these have higher rates of visceral metastases 1
Common Pitfalls to Avoid
- Do not perform excisional biopsy or surgical resection without pre-treatment histological diagnosis 1
- Do not start with ultrasound—it has poor accuracy for deep masses and intra-abdominal locations 2
- Do not use MRI as initial study for intra-abdominal masses; CT is preferred for this anatomic location 1, 2
- Do not biopsy before imaging if you cannot provide definitive treatment—refer first 2
- Do not rely on chest X-ray alone for staging if sarcoma is confirmed; CT chest is required for intermediate and high-grade tumors 1
Differential Considerations
While evaluating this mass, recognize that the hepatic flexure location raises additional considerations beyond typical soft tissue sarcomas:
- The mass could represent primary colonic pathology
- Could be metastatic disease to soft tissues
- Could be a true soft tissue sarcoma (leiomyosarcoma, liposarcoma variants)
- Histological diagnosis via core biopsy is essential to distinguish these 1
The key principle: imaging first (CT with contrast), specialist referral before biopsy, core needle biopsy for diagnosis, then definitive treatment planning based on histology and complete staging.